MLchartDataset catalogue

Rapamune

Term · Oncology and biomedicine · MLC-T-ONC-007213

A drug used to keep the body from rejecting organ and bone marrow transplants. Rapamune blocks certain white blood cells that can reject foreign tissues and organs. It also blocks a protein that is involved in cell division. It is a type of antibiotic, a type of immunosuppressant, and a type of serine/threonine kinase inhibitor. Rapamune was previously called rapamycin. Also called sirolimus.

Table 1. Record
IdentifierMLC-T-ONC-007213
FieldOncology and biomedicine
Synonymssirolimus
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-007213",
  "term": "Rapamune",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to keep the body from rejecting organ and bone marrow transplants. Rapamune blocks certain white blood cells that can reject foreign tissues and organs. It also blocks a protein that is involved in cell division. It is a type of antibiotic, a type of immunosuppressant, and a type of serine/threonine kinase inhibitor. Rapamune was previously called rapamycin. Also called sirolimus.",
  "synonyms": [
    "sirolimus"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/rapamune/"
}

Record 14,065 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.